Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Bladder Cancer

Free Subscription Articles published in Oncol Rep Retrieve available abstracts of 21 articles: HTML format

Single Articles

February 2024
1. CHEN F, Chen X, Yang D, Che X, et al
   [Retracted] Isoquercitrin inhibits bladder cancer progression in vitro and in vivo by regulating the PI3K/Akt and PKC signaling pathways.
   Oncol Rep. 2024;51:25.
   PubMed     Abstract available
   
   
   January 2024
2. SONG W, Li Z, Xia M, Xiao W, et al
   Regulation of Drp1 and enhancement of mitochondrial fission by the deubiquitinating enzyme PSMD14 facilitates the proliferation of bladder cancer cells.
   Oncol Rep. 2024;51:6.
   PubMed     Abstract available
   
   
   
3. YE G, Tu L, Li Z, Li X, et al
   SYNPO2 promotes the development of BLCA by upregulating the infiltration of resting mast cells and increasing the resistance to immunotherapy.
   Oncol Rep. 2024;51:14.
   PubMed     Abstract available
   
   
   September 2023
4. HAO Y, He W, Wang H, Rui W, et al
   Forkhead box F1 functions as a novel prognostic biomarker and induces caspase‑dependent apoptosis in bladder cancer.
   Oncol Rep. 2023;50:173.
   PubMed     Abstract available
   
   
   June 2023
5. HO JN, Jeon JS, Kim DH, Ryu H, et al
   CUDC‑907 suppresses epithelial‑mesenchymal transition, migration and invasion in a 3D spheroid model of bladder cancer.
   Oncol Rep. 2023;49:130.
   PubMed     Abstract available
   
   
   May 2023
6. CHEN JX, Chen DM, Wang D, Xiao Y, et al
   METTL3/YTHDF2 m6A axis promotes the malignant progression of bladder cancer by epigenetically suppressing RRAS.
   Oncol Rep. 2023;49:94.
   PubMed     Abstract available
   
   
   
7. LIU X, Tong Y, Huang Q, He Y, et al
   CircRPPH1 accelerates the proliferation and migration of bladder cancer via enhancing the STAT3 signaling pathway.
   Oncol Rep. 2023;49:103.
   PubMed     Abstract available
   
   
   
8. ZHANG C, Wang R, Li M, Yang Q, et al
   Long non‑coding RNA BLACAT2/miR‑378a‑3p/YY1 feedback loop promotes the proliferation, migration and invasion of uterine corpus endometrial carcinoma.
   Oncol Rep. 2023;49:108.
   PubMed     Abstract available
   
   
   January 2023
9. ZHAO Y, Ren P, Yang Z, Wang L, et al
   Inhibition of SND1 overcomes chemoresistance in bladder cancer cells by promoting ferroptosis.
   Oncol Rep. 2023;49:16.
   PubMed     Abstract available
   
   
   November 2022
10. WU D, Niu X, Tao J, Li P, et al
    [Corrigendum] MicroRNA3795p plays a tumorsuppressive role in human bladder cancer growth and metastasis by directly targeting MDM2.
    Oncol Rep. 2022;48.
    PubMed     Abstract available
    
    
    October 2022
11. NAKAI Y, Tatsumi Y, Hori S, Morizawa Y, et al
    5Aminolevurinic acid inhibits the proliferation of bladder cancer cells by activating heme synthesis.
    Oncol Rep. 2022;48.
    PubMed     Abstract available
    
    
    July 2022
12. XIAO H, Li H, Yu G, Xiao W, et al
    [Corrigendum] MicroRNA10b promotes migration and invasion through KLF4 and HOXD10 in human bladder cancer.
    Oncol Rep. 2022;48.
    PubMed     Abstract available
    
    
    February 2022
13. GAO X, Liu J, Fan D, Li X, et al
    Berberine enhances gemcitabineinduced cytotoxicity in bladder cancer by downregulating Rad51 expression through inactivating the PI3K/Akt pathway.
    Oncol Rep. 2022;47.
    PubMed     Abstract available
    
    
    August 2021
14. HUANG J, He QM, Wu Q, Zhou WM, et al
    Long noncoding RNA 00858 knockdown alleviates bladder cancer via regulation of the miR30645p/CTGF axis.
    Oncol Rep. 2021;46.
    PubMed     Abstract available
    
    
    April 2021
15. CHEN X, Chen S
    LINC00649 promotes bladder cancer malignant progression by regulating the miR15a5p/HMGA1 axis.
    Oncol Rep. 2021;45:1.
    PubMed     Abstract available
    
    
    March 2021
16. JIA M, Su B, Mo L, Qiu W, et al
    Circadian clock protein CRY1 prevents paclitaxelinduced senescence of bladder cancer cells by promoting p53 degradation.
    Oncol Rep. 2021;45:1033-1043.
    PubMed     Abstract available
    
    
    
17. CHOU KY, Chang AC, Tsai TF, Lin YC, et al
    MicroRNA34a5p serves as a tumor suppressor by regulating the cell motility of bladder cancer cells through matrix metalloproteinase2 silencing.
    Oncol Rep. 2021;45:911-920.
    PubMed     Abstract available
    
    
    January 2021
18. LI S, Zhao Y, Chen X
    Microarray expression profile analysis of circular RNAs and their potential regulatory role in bladder carcinoma.
    Oncol Rep. 2021;45:239-253.
    PubMed     Abstract available
    
    
    November 2020
19. CHEN Y, Xu T, Xie F, Wang L, et al
    Evaluating the biological functions of the prognostic genes identified by the Pathology Atlas in bladder cancer.
    Oncol Rep. 2020 Nov 13. doi: 10.3892/or.2020.7853.
    PubMed     Abstract available
    
    
    
20. ZHANG Z, Chen F, Zhan H, Chen L, et al
    lncRNA CASC9 sponges miR7583p to promote proliferation and EMT in bladder cancer by upregulating TGFbeta2.
    Oncol Rep. 2020 Nov 13. doi: 10.3892/or.2020.7852.
    PubMed     Abstract available
    
    
    
21. SHEN C, Wang Y, Wu Z, Da, et al
    Long noncoding RNAs, ENST00000598996 and ENST00000524265, are correlated with favorable prognosis and act as potential tumor suppressors in bladder cancer.
    Oncol Rep. 2020;44:1831-1850.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.